With the emergence of AI as an increasingly dominant force in industry (and society), much of the early discussion around AI in biopharma has tended to treat it largely as an abstraction. Advocates and investors insist AI is a transformative superhuman technology poised to domesticate R&D, while cynics, including many grizzled drug hunters, tend to... Read More
source & further reading
realclearhealth.com — original article
What AI Really Adds to Personal Health Data
When the Denominator Disappears: FDA's Next Evolution Should Be Causal Inference